Συγγραφείς:
Papageorgiou, S.G.
Kontos, C.K.
Kotsianidis, I.
Karousi, P.
Symeonidis, A.
Galanopoulos, A.
Bouchla, A.
Hatzimichael, E.
Repousis, P.
Zikos, P.
Viniou, N.-A.
Poulakidas, E.
Vassilakopoulos, T.P.
Diamantopoulos, P.
Mparmparousi, D.
Bouronikou, E.
Papadaki, H.
Panayiotidis, P.
Pappa, V.
Λέξεις-κλειδιά:
azacitidine; azacitidine, acute myeloid leukemia; aged; bone marrow suppression; bone marrow toxicity; cancer growth; cancer risk; comorbidity; controlled study; drug efficacy; female; follow up; Greece; human; International Prognostic Scoring System; Letter; major clinical study; male; myelodysplastic syndrome; oligoblastic acute myeloid leukemia; oligoblastic acute myeloid leukemia; overall survival; priority journal; retrospective study; single drug dose; treatment failure; treatment response; very elderly, Aged; Azacitidine; Greece; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Retrospective Studies
